Health officials are encouraging healthcare providers to move away from prescribing traditional blue inhalers for asthma and instead use newer medication options, described as part of a “life-saving” change in asthma treatment. The reports say that more than a million people are already using the newer asthma medication. The guidance is directed at providers and is framed as an effort to improve patient care and standardize prescribing practices across services. While the articles emphasize the scale of current use, they do not provide detailed clinical data within the provided text, such as specific effectiveness comparisons, eligibility criteria, or timelines for replacing existing inhalers. The overall message across the coverage is that authorities want providers to steer patients toward the updated medication approach rather than relying on traditional blue inhalers. The guidance appears to be part of broader health policy aimed at changing routine asthma prescribing.